About
Featured Companies
Articles
News
Contact
Sponsors
Featured Companies
Subscribe to Excellence
Welcome aboard! Your submission has been received and you are now a member of the MedicalGold.ca community.
Oops! Something went wrong while submitting the form. Please check the format of your entry.
MindMed
Featured Articles
MindMed
All Companies Posts
PharmAla Biotech
FendX Technologies
Numinus
Cybin Inc.
Algernon Pharmaceuticals
TRYP Therapeutics
Biovaxys
Medicenna Therapeutics
Izotropic
Mar 10, 2023
Canada's Largest Bank Sees 60% Upside In This Psychedelic Stock
Aug 24, 2022
Exclusive Interview With Scott Freeman, Biotech Investor and Former CMO of MindMed - PART I
Aug 24, 2022
Exclusive Interview With Scott Freeman, Biotech Investor and Former CMO of MindMed - PART II
Aug 16, 2022
MindMed 2Q22 Update: Shares Jump On Key Catalysts
Apr 4, 2022
Robert Barrow, CEO Delivers 2021 Shareholder Update
Mar 22, 2022
Has MindMed Hit A Double-Bottom?
Jan 25, 2022
BREAKING NEWS: MindMed Shares Surge on FDA Clearance for Phase 1 Study
Nov 8, 2021
Update: MindMed Expands Psychedelic Pipeline and Receives Positive Human Data
Jul 12, 2021
MindMed: Developing a holistic approach to treating mental illness with psychedelic compounds
